A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise
- Chang Hee Jung
- , Cheol Young Park
- , Kyu Joeng Ahn
- , Nan Hee Kim
- , Hak Chul Jang
- , Moon Kyu Lee
- , Joong Yeol Park
- , Choon Hee Chung
- , Kyung Wan Min
- , Yeon Ah Sung
- , Jeong Hyun Park
- , Sung Jin Kim
- , Hyo Jung Lee
- , Sung Woo Park
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations